by Haja Mo November 15, 2025 Business A gene therapy for Duchenne muscular dystrophy caused complications to the liver, prompting a review of its use for younger patients. Previous Story Judge to Approve Purdue Pharma Bankruptcy, Releasing Billions for Opioid Plaintiffs Next Story Trump Administration Lifts Some Food Tariffs in Effort to Ease Prices